Globe Life Inc. Q3 2026 Earnings Recap

Globe Life’s shares fell 0.7% after earnings, a roughly flat reaction. Operating income per share edged up 1%, while GAAP net income per share declined 2%; the quarter also included underwriting pressure at United American and Evri, and softer life-margin results before adjustment effects.

Key Takeaways

• Net operating income was $379 million, or $4.84 per share, up 1% year over year; net income was $361 million, or $4.62 per share, down 2%.
• Total premium revenue grew 7%. Management expects full-year growth of about 6.5%, with life premiums projected to grow 2.5%–2.75% and health premiums about 15%.
• Life underwriting margin fell 5% to $458 million, primarily due to assumption-update fluctuations; excluding those effects, it would have risen about 3%. Health underwriting margin increased 7% to $116 million.
• United American’s underwriting results were hurt by a CMS process change affecting Medicare supplement claims and high-severity claims at Evri.
• American Income net life sales were flat at $97 million as a 7% year-over-year decline in agent count was offset by higher productivity; producing agent count was essentially flat sequentially.